Cardax Pharmaceuticals Inc — Form D
Cardax Pharmaceuticals Inc of Aiea, HI, a company, filed a Form D exempt-offering notice with the SEC on 2010-09-28. The offering totals $2.0M, of which $550K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-09-28
- Form: D
- Accession: 0001408223-10-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.0M
- Amount sold: $550K
- Remaining: $1.4M
- Investors: 4
- Date of first sale: 2010-09-23
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-148265
Issuer
- Name: Cardax Pharmaceuticals Inc
- CIK: 0001408223
- Entity type: Corporation
- Jurisdiction: DE
- Incorporated: 2006
- Address: 99-193 Aiea Hights Drive, Aiea, HI, 96701
- Phone: 808-457-1375
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Frank J Herringer | Director | Honolulu, HI |
| Nicholas J Mitsakos | Director | Honolulu, HI |
| Frederic J Pashkow | Director | Honolulu, HI |
| David G Watumull | Director | Honolulu, HI |
| Frederic J Pashkow | Executive Officer | Honolulu, HI |
| David G Watumull | Executive Officer | Honolulu, HI |
| Nicholas Mitsakos | Director | Irvine, CA |
| Frank Herringer | Director | Aiea, HI |
| Fredric J Pashkow | Director | Aiea, HI |
| Fredric J Pashkow | Executive Officer | Aiea, HI |
| Thomas H Goodin | Executive Officer | Aiea, HI |
Other filings by this issuer (1)
More